Jon Getzinger
Chief Sales & Marketing Officer, Genovia Bio Division
Lonergan Partners is pleased to announce that Jon Getzinger has been named Chief Sales &Marketing Officer, Genovia Bio Division of Synthetic Genomics Inc. The search was led by Dotty Schaffer.
About Jon
Prior to joining Genovia Bio, Jon Getzinger served as Chief Sales and Marketing Officer at Ocean Nutrition Canada responsible for sales, marketing and regulatory affairs. Jon has held Executive and Senior level positions in Sales, Marketing and General Management for the past twenty years in a variety of industries focusing on developing high performance teams with high degrees of accountability especially in the midst of culture change.
Some of the teams that Jon has successfully led include: EVP of Sales and Marketing at RTI, Commercial Director for two global business Units at Cargill and VP North America and GM Asia Pacific for NutraSweet.
Jon received his bachelor’s degree from the University of Michigan and his Master’s in Business from Washington University in St. Louis, Missouri and has served on a variety of boards including Washington University’s Executive Programs and the Omega -3 trade organization, GOED.
About Synthetic Genomics
Synthetic Genomics Inc., a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key research and business programs including: developing new synthetic DNA products and technologies through its subsidiary, SGI-DNA; algae biofuels; new and improved food and nutritional products; and clean water technology. SGI is also involved in synthetically derived vaccine development through Synthetic Genomic Vaccines Inc. (SGVI), a business unit co-founded with the J. Craig Venter Institute; and in developing sustainable crops such as castor and sweet sorghum and agricultural products through AgraCast, a company co-founded with Plenus S.A. de C.V.
We are thrilled to have Jon Getzinger join our team to lead our commercial development efforts for our algal ingredients. Jon brings a strong track record of success in commercializing and developing sales and markets for innovative ingredients, such as those under development at Synthetic Genomics, Genovia Bio Division.
Jim Flatt, President, Genovia Bio Division, Synthetic Genomics
After surveying the market for exciting opportunities, it was clear to me that Synthetic Genomics topped the list. The potential solutions that this company brings to a variety of markets both domestically as well as globally is without equal in this space. I am extremely pleased to have been chosen to lead commercial development for such a distinguished company.
Jon Getzinger, Chief Sales & Marketing Officer, Genovia Bio Division, Synthetic Genomics
Jon brings a track record of success in both commercializing new products and building great teams. His sales and marketing abilities will help establish Genovia Bio as the leader in the algal ingredients space.
Dotty Schaffer, Partner, Lonergan Partners